Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Production of a recombinant industrial protein using barley cell cultures.
- A. Ritala, E. Wahlström, +5 authors A. M. Nuutila
- Biology, Medicine
- Protein expression and purification
- 1 June 2008
The use of recombinant DNA-based protein production using genetically modified plants could provide a reproducible, consistent quality, safe, animal-component free, origin-traceable, and… Expand
Recent advances in the malting and brewing industry 1 Based on a lecture held at the symposium `Biot
- M. Linko, A. Haikara, A. Ritala, M. Penttilä
- Biology
- 27 October 1998
Abstract Brewing is often mentioned as a typical example of traditional or old biotechnology, because of its extremely long history. However, the modern malting and brewing industry applies a whole… Expand
Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody
- S. T. Häkkinen, Nicole Raven, +8 authors A. Ritala
- Biology, Medicine
- Biotechnology and bioengineering
- 1 February 2014
Recombinant pharmaceutical proteins expressed in hairy root cultures can be secreted into the medium to improve product homogeneity and to facilitate purification, although this may result in… Expand
Production of a recombinant full-length collagen type I alpha-1 and of a 45-kDa collagen type I alpha-1 fragment in barley seeds.
- K. Eskelin, A. Ritala, +6 authors Nuutila Anna Maria
- Biology, Medicine
- Plant biotechnology journal
- 1 September 2009
Recombinant DNA technology can be used to design and express collagen and gelatin-related proteins with predetermined composition and structure. Barley seed was chosen as a production host for a… Expand
Scale-up of hydrophobin-assisted recombinant protein production in tobacco BY-2 suspension cells.
- Lauri J Reuter, M. J. Bailey, J. Joensuu, A. Ritala
- Biology, Medicine
- Plant biotechnology journal
- 1 May 2014
Plant suspension cell cultures are emerging as an alternative to mammalian cells for production of complex recombinant proteins. Plant cell cultures provide low production cost, intrinsic safety and… Expand
Expression of fungal thermotolerant endo-1,4-β-glucanase in transgenic barley seeds during germination
- A. M. Nuutila, A. Ritala, R. Skadsen, L. Mannonen, V. Kauppinen
- Biology, Medicine
- Plant Molecular Biology
- 1 December 1999
The malting quality of two barley cultivars, Kymppi and Golden Promise, was modified to better meet the requirements of the brewing process. The egl1 gene, coding for fungal thermotolerant… Expand
Evaluation of tobacco (Nicotiana tabacum L. cv. Petit Havana SR1) hairy roots for the production of geraniol, the first committed step in terpenoid indole alkaloid pathway.
- A. Ritala, Lemeng Dong, +11 authors K. Oksman-Caldentey
- Biology, Medicine
- Journal of biotechnology
- 20 April 2014
The terpenoid indole alkaloids are one of the major classes of plant-derived natural products and are well known for their many applications in the pharmaceutical, fragrance and cosmetics industries.… Expand
Fertile transgenic barley by particle bombardment of immature embryos
- A. Ritala, K. Aspegren, +6 authors Tor-Magnus Enari
- Biology, Medicine
- Plant Molecular Biology
- 2004
Transgenic, fertile barley (Hordeum vulgare L.) from the Finnish elite cultivar Kymppi was obtained by particle bombardment of immature embryos. Immature embryos were bombarded to the embryonic axis… Expand
Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
- A. Ritala, S. T. Häkkinen, M. Toivari, M. Wiebe
- Biology, Medicine
- Front. Microbiol.
- 13 October 2017
By 2050, the world would need to produce 1,250 million tonnes of meat and dairy per year to meet global demand for animal-derived protein at current consumption levels. However, growing demand for… Expand
Plant cells as pharmaceutical factories.
- H. Rischer, S. T. Häkkinen, +5 authors K. Oksman-Caldentey
- Biology, Medicine
- Current pharmaceutical design
- 31 August 2013
Molecules derived from plants make up a sizeable proportion of the drugs currently available on the market. These include a number of secondary metabolite compounds the monetary value of which is… Expand